You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 2, 2025

Details for Patent: 10,206,932


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,206,932 protect, and when does it expire?

Patent 10,206,932 protects BIJUVA and is included in one NDA.

This patent has nine patent family members in nine countries.

Summary for Patent: 10,206,932
Title:Natural combination hormone replacement formulations and therapies
Abstract: Pharmaceutical compositions for co-administering estradiol and progesterone to a human subject in need thereof are provided. In some embodiments, the pharmaceutical composition comprises solubilized estradiol, suspended progesterone, and a solubilizing agent comprising a medium chain (C6-C12) oil.
Inventor(s): Bernick; Brian A. (Boca Raton, FL), Persicaner; Peter H. R. (Boca Raton, FL), Amadio; Julia M. (Boca Raton, FL)
Assignee: TherapeuticsMD, Inc. (Boca Raton, FL)
Application Number:14/719,933
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 10,206,932
Patent Claim Types:
see list of patent claims
Use; Composition;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 10,206,932

Introduction

Patent 10,206,932, assigned to TherapeuticsMD, is a significant intellectual property asset in the pharmaceutical industry. To delve into the details of this patent, it is crucial to understand the patent's scope, claims, and the broader patent landscape it operates within.

Patent Overview

Patent Number and Title

  • The patent in question is U.S. Patent 10,206,932. While the specific title is not provided in the sources, it is associated with TherapeuticsMD's product IMVEXXY®, which is a vaginal insert for the treatment of moderate to severe dyspareunia (painful sex) due to menopause.

Assignee and Inventors

  • The patent is assigned to TherapeuticsMD, a company specializing in women’s healthcare products. The inventors listed would typically include the researchers and scientists who developed the formulation and delivery system of IMVEXXY®.

Patent Claims

Claim Structure

  • Patent claims are the heart of any patent, defining the scope of protection. For U.S. Patent 10,206,932, the claims would typically include:
    • Independent Claims: These are the broadest claims that define the invention. They are crucial for determining the patent's scope and are often the subject of litigation and licensing discussions.
    • Dependent Claims: These claims are narrower and build upon the independent claims, providing additional specificity and protection[3].

Claim Analysis

  • The length and count of independent claims can provide insights into the patent's scope. Research suggests that narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].
  • For IMVEXXY®, the claims would likely focus on the unique formulation, the delivery mechanism, and any specific methods of use or administration.

Patent Scope

Metrics for Measuring Scope

  • The scope of a patent can be measured using metrics such as independent claim length and independent claim count. These metrics have explanatory power for several correlates of patent scope, including patent maintenance payments, forward citations, and the breadth of patent classes[3].

Impact on Innovation

  • The scope of the patent can influence innovation by affecting licensing and litigation costs. Broader patents may lead to increased costs and diminished incentives for innovation, while narrower patents may facilitate more focused and efficient innovation[3].

Patent Examination Process

Examination and Grant

  • The examination process for U.S. Patent 10,206,932 would have involved a thorough review by the USPTO to ensure the claims are novel, non-obvious, and meet the requirements for patentability.
  • The process tends to narrow the scope of patent claims, with longer examination durations often resulting in more significant scope reductions[3].

Patent Landscape

Competitive Environment

  • The patent landscape for women’s healthcare products, particularly those addressing menopausal symptoms, is competitive. Other companies may hold patents for similar products, and understanding these patents is crucial for navigating the market.
  • Tools like the USPTO's Patent Public Search and international databases such as those provided by the European Patent Office (EPO) and the World Intellectual Property Organization (WIPO) can help in identifying related patents[1].

Citations and Prior Art

  • The Common Citation Document (CCD) application can provide insights into prior art cited by multiple patent offices, helping to understand the global context of the invention[1].
  • Forward and backward citations can also indicate the patent's impact and its position within the broader technological field.

Enforcement and Litigation

Small Claims Patent Court Considerations

  • In the context of enforcement, the concept of a small claims patent court, as studied by the Administrative Conference of the United States (ACUS), could potentially impact how disputes related to this patent are resolved. Such a court could provide a more streamlined and cost-effective way to address patent infringement claims[5].

Public Access and Search Tools

USPTO Resources

  • The USPTO offers several tools for searching and analyzing patents, including the Patent Public Search tool, Global Dossier, and the Patent and Trademark Resource Centers (PTRCs). These resources can be used to gather detailed information about U.S. Patent 10,206,932 and related patents[1].

Data Download and Analysis

  • Databases like PatentsView provide extensive data sets that can be downloaded and analyzed to understand the patent landscape, including information on citations, assignees, and inventors[4].

Key Takeaways

  • Patent Claims: The claims of U.S. Patent 10,206,932 define the scope of protection for IMVEXXY® and are critical for understanding the patent's value and enforceability.
  • Patent Scope: Metrics such as claim length and count can help measure the patent's scope and its impact on innovation.
  • Examination Process: The patent examination process likely narrowed the claims, ensuring they meet the requirements for patentability.
  • Patent Landscape: Understanding the competitive environment and prior art is essential for navigating the market and enforcing the patent.
  • Enforcement: The potential for a small claims patent court could influence how disputes related to this patent are resolved.

FAQs

Q: What is the significance of independent claims in a patent?

  • Independent claims are the broadest claims that define the invention and are crucial for determining the patent's scope and enforceability.

Q: How can the scope of a patent be measured?

  • The scope of a patent can be measured using metrics such as independent claim length and independent claim count, which have explanatory power for several correlates of patent scope.

Q: What is the role of the USPTO's Patent Public Search tool?

  • The Patent Public Search tool provides enhanced access to prior art, allowing users to search and analyze patents more effectively.

Q: How does the examination process affect patent claims?

  • The examination process tends to narrow the scope of patent claims, with longer examination durations often resulting in more significant scope reductions.

Q: What is the Common Citation Document (CCD) application used for?

  • The CCD application consolidates prior art cited by multiple patent offices, enabling users to visualize search results for the same invention on a single page.

Sources

  1. USPTO: Search for patents - USPTO
  2. TherapeuticsMD: TherapeuticsMD Product Patents
  3. SSRN: Patent Claims and Patent Scope
  4. PatentsView: Data Download Tables - PatentsView
  5. ACUS: U.S. Patent Small Claims Court

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,206,932

Showing 1 to 2 of 2 entries

International Family Members for US Patent 10,206,932

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Argentina 100562 ⤷  Try for Free
Australia 2015264003 ⤷  Try for Free
Canada 2947767 ⤷  Try for Free
European Patent Office 3145489 ⤷  Try for Free
Japan 2017516768 ⤷  Try for Free
South Korea 20170005819 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 6 of 6 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.